| Pharmaceutical active ingredients: |
| HydrochlorothiazideSpironolactone |
| Available forms, composition and doses of Spironazide: |
| N / A |
| Spironazide medical category: |
| Human:Mineralocorticoid (Aldosterone) receptor antagonistsThiazide diuretics |
| Indications and usages, anatomical therapeutic chemical and diseases classification codes: |
| C03DA01 - SpironolactoneC03EA01 - Hydrochlorothiazide and potassium-sparing agents |
| Pharmaceutical companies: manufacturers, researchers, developers, local distributors and suppliers: |
| Unidentified Pharmaceutical Company |
| Trade name |
Active ingredients |
Pharmaceutical company |
|
Spira-Dine | Aspirin | Unidentified Pharmaceutical Company |
| Spiramin | Tranexamic Acid | Unidentified Pharmaceutical Company |
| Spirocid | Acetarsol | Unidentified Pharmaceutical Company |
| Spiroctanie | Spironolactone | Unidentified Pharmaceutical Company |
| Spirofulvin | Griseofulvin | Unidentified Pharmaceutical Company |
| Spirone | Spironolactone | Unidentified Pharmaceutical Company |
| Spironocompren | Spironolactone | Unidentified Pharmaceutical Company |
| Spirozid | Acetarsol | Unidentified Pharmaceutical Company |
| Spirozide | Hydrochlorothiazide; Spironolactone | Unidentified Pharmaceutical Company |
| Spitacin | Ciprofloxacin | Unidentified Pharmaceutical Company |